These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22197309)

  • 21. Eya1-Six1 interaction is sufficient to induce hair cell fate in the cochlea by activating Atoh1 expression in cooperation with Sox2.
    Ahmed M; Wong EY; Sun J; Xu J; Wang F; Xu PX
    Dev Cell; 2012 Feb; 22(2):377-90. PubMed ID: 22340499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A FBXO7/EYA2-SCF
    Shen JZ; Qiu Z; Wu Q; Zhang G; Harris R; Sun D; Rantala J; Barshop WD; Zhao L; Lv D; Won KA; Wohlschlegel J; Sangfelt O; Laman H; Rich JN; Spruck C
    Mol Cell; 2022 Mar; 82(6):1123-1139.e8. PubMed ID: 35182481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression.
    Morales CR; Li DL; Pedrozo Z; May HI; Jiang N; Kyrychenko V; Cho GW; Kim SY; Wang ZV; Rotter D; Rothermel BA; Schneider JW; Lavandero S; Gillette TG; Hill JA
    Sci Signal; 2016 Apr; 9(422):ra34. PubMed ID: 27048565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-219 inhibits cell viability and metastasis in papillary thyroid carcinoma by targeting EYA2.
    Liu HM; Dong AB; Hua H; Sun YH; Wang JR; Yu QQ; Zhang JH; Sun WH
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9556-9564. PubMed ID: 33015798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-29a promotes pathological cardiac hypertrophy by targeting the PTEN/AKT/mTOR signalling pathway and suppressing autophagy.
    Shi JY; Chen C; Xu X; Lu Q
    Acta Physiol (Oxf); 2019 Oct; 227(2):e13323. PubMed ID: 31162869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thioredoxin-1 maintains mitochondrial function via mechanistic target of rapamycin signalling in the heart.
    Oka SI; Chin A; Park JY; Ikeda S; Mizushima W; Ralda G; Zhai P; Tong M; Byun J; Tang F; Einaga Y; Huang CY; Kashihara T; Zhao M; Nah J; Tian B; Hirabayashi Y; Yodoi J; Sadoshima J
    Cardiovasc Res; 2020 Aug; 116(10):1742-1755. PubMed ID: 31584633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis.
    Miller SJ; Lan ZD; Hardiman A; Wu J; Kordich JJ; Patmore DM; Hegde RS; Cripe TP; Cancelas JA; Collins MH; Ratner N
    Oncogene; 2010 Jan; 29(3):368-79. PubMed ID: 19901965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eya2 promotes cell cycle progression by regulating DNA damage response during vertebrate limb regeneration.
    Sousounis K; Bryant DM; Martinez Fernandez J; Eddy SS; Tsai SL; Gundberg GC; Han J; Courtemanche K; Levin M; Whited JL
    Elife; 2020 Mar; 9():. PubMed ID: 32142407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterning of the third pharyngeal pouch into thymus/parathyroid by Six and Eya1.
    Zou D; Silvius D; Davenport J; Grifone R; Maire P; Xu PX
    Dev Biol; 2006 May; 293(2):499-512. PubMed ID: 16530750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compensation of the AKT signaling by ERK signaling in transgenic mice hearts overexpressing TRIM72.
    Ham YM; Mahoney SJ
    Exp Cell Res; 2013 Jun; 319(10):1451-62. PubMed ID: 23567182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deletion of MLIP (muscle-enriched A-type lamin-interacting protein) leads to cardiac hyperactivation of Akt/mammalian target of rapamycin (mTOR) and impaired cardiac adaptation.
    Cattin ME; Wang J; Weldrick JJ; Roeske CL; Mak E; Thorn SL; DaSilva JN; Wang Y; Lusis AJ; Burgon PG
    J Biol Chem; 2015 Oct; 290(44):26699-714. PubMed ID: 26359501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meningioma transcription factors link cell lineage with systemic metabolic cues.
    Du Z; Brewster R; Merrill PH; Chmielecki J; Francis J; Aizer A; Abedalthagafi M; Sholl LM; Geffers L; Alexander B; Santagata S
    Neuro Oncol; 2018 Sep; 20(10):1331-1343. PubMed ID: 29660031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-219a-5p represses migration and invasion of osteosarcoma cells via targeting EYA2.
    Zhu X; Chen L; Lin J
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1004-S1010. PubMed ID: 30449183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Six1 and Eya1 are critical regulators of peri-cloacal mesenchymal progenitors during genitourinary tract development.
    Wang C; Gargollo P; Guo C; Tang T; Mingin G; Sun Y; Li X
    Dev Biol; 2011 Dec; 360(1):186-94. PubMed ID: 21968101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The alpha subunits of Gz and Gi interact with the eyes absent transcription cofactor Eya2, preventing its interaction with the six class of homeodomain-containing proteins.
    Fan X; Brass LF; Poncz M; Spitz F; Maire P; Manning DR
    J Biol Chem; 2000 Oct; 275(41):32129-34. PubMed ID: 10906137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The SIX1-EYA transcriptional complex as a therapeutic target in cancer.
    Blevins MA; Towers CG; Patrick AN; Zhao R; Ford HL
    Expert Opin Ther Targets; 2015 Feb; 19(2):213-25. PubMed ID: 25555392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant expression of homeobox gene SIX1 in Hodgkin lymphoma.
    Nagel S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
    Oncotarget; 2015 Nov; 6(37):40112-26. PubMed ID: 26473286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Berberine Attenuates Cardiac Hypertrophy Through Inhibition of mTOR Signaling Pathway.
    Chen X; Jiang X; Cheng C; Chen J; Huang S; Xu M; Liu S
    Cardiovasc Drugs Ther; 2020 Aug; 34(4):463-473. PubMed ID: 32394178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pax3 is essential for skeletal myogenesis and the expression of Six1 and Eya2.
    Ridgeway AG; Skerjanc IS
    J Biol Chem; 2001 Jun; 276(22):19033-9. PubMed ID: 11262400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testosterone induces cardiomyocyte hypertrophy through mammalian target of rapamycin complex 1 pathway.
    Altamirano F; Oyarce C; Silva P; Toyos M; Wilson C; Lavandero S; Uhlén P; Estrada M
    J Endocrinol; 2009 Aug; 202(2):299-307. PubMed ID: 19474060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.